Andreea L. Cretu, PhD, MBA
Healthcare & Life Sciences Leader | Innovation, Startups & Strategic Partnerships
Innovation and ecosystem leader with 10+ years of cross-sector experience bridging science, startups, and industry. I design and scale entrepreneurship programs, strategic partnerships, and funding pathways that accelerate adoption of emerging healthcare technologies including AI solutions.
Zurich, Switzerland
About Me
"👋 Hello! I’m Andreea, a connector by nature, a neuroscientist by training, and an ecosystem builder by choice."
For the past decade, my career has revolved around understanding people and systems, from decoding how the brain works during my PhD in Neuroscience, to helping global pharma clients refine their commercial strategies as a consultant, to now building the next generation of health innovators through academic entrepreneurship.
With a PhD and an MBA, I combine scientific depth with a strategic mindset to help research teams and early founders translate great ideas into real impact. Currently, I lead initiatives at the University of Zurich that connect startups, investors, and academia to strengthen Switzerland’s life science and medtech ecosystem.
I’m energetic, fast-paced, and rarely say no to a good idea, which might explain why I’m constantly found at startup events, panels, or mentoring sessions.
🕵️♀️ Fun fact: I once wanted to be a policewoman. Turns out I still love detective work, just now it’s about finding the right people, partners, and paths to make innovation happen.
I believe progress happens when diverse minds meet, and I’m here to make sure they do.
Core Competencies
Hover over each area below to see how I translate these skills into strategic action.
Startup Ecosystem, Advisory & Community Impact
Building bridges across innovation, entrepreneurship, and diverse professional networks.
Events & Engagements
Showcasing active participation and panels in key industry summits.
Featured Publications & Insights
A selection of co-authored white papers on neuroscience and life sciences commercialization.
Spinal Muscular Atrophy (Part 1)
Analyzing the clinical market landscape and emerging molecular therapies.
Read White Paper
Spinal Muscular Atrophy (Part 2)
Continuing the strategic analysis of SMA pipelines and global market dynamics.
Read Insight
Taboo Treatments in CNS
Exploring regulatory and launch frameworks for novel psychoactive and psychedelic therapies.
Read White Paper
The CNS Market: Review & Outlook
Strategic deep dives and launch model predictions in central nervous system research.
Read White Paper
Alzheimer's Disease Market Overview
Comprehensive review of strategic, reimbursement, and delivery challenges in Alzheimer's drug developments.
Read White Paper
Career & Education Timeline
Click on any timeline card with an arrow to expand details about achievements and milestones.